PuSH - Publikationsserver des Helmholtz Zentrums München

Weidle, U.H.* ; Dickopf, S.* ; Hintermair, C. ; Kollmorgen, G.* ; Birzele, F.* ; Brinkmann, U.*

The role of micro RNAs in breast cancer metastasis: Preclinical Validation and potential therapeutic targets.

Cancer Genomics Proteomics 15, 17-39 (2018)
Verlagsversion DOI PMC
Open Access Gold
Despite the approval of several molecular therapies in the last years, breast cancer-associated death ranks as the second highest in women. This is due to metastatic disease, which represents a challenge for treatment. A better understanding of the molecular mechanisms of metastasis is, therefore, of paramount importance. In this review we summarize the role of micro RNAs (miRs) involved in metastasis of breast cancer. We present an overview on metastasis-promoting, -suppressing and context-dependent miRs with both activities. We have categorized the corresponding miRs according to their target classes, interaction with stromal cells or exosomes. The pathways affected by individual miRs are outlined in regard to in vitro properties, activity in metastasis-related in vivo models and clinical significance. Current approaches that may be suitable for therapeutic inhibition or restauration of miR activity are outlined. Finally, we discuss the delivery bottlenecks which present as a major challenge in nucleic acid (miR)-based therapies.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
2.432
0.708
34
42
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Schlagwörter Colonization Of Distinct Organs ; Epithelial-mesenchymal Transition (emt) ; Exosomes ; Mesenchymal-epithelial Transition (met) ; Metastasis-related In Vivo Models ; Migration And Invasion ; Review ; Tumor Cell/stromal Cell Interactions
Sprache
Veröffentlichungsjahr 2018
Prepublished im Jahr 2017
HGF-Berichtsjahr 2017
ISSN (print) / ISBN 1109-6535
e-ISSN 1790-6245
Quellenangaben Band: 15, Heft: 1, Seiten: 17-39 Artikelnummer: , Supplement: ,
Verlag International Institute of Anticancer Research
Begutachtungsstatus Peer reviewed
POF Topic(s) 30203 - Molecular Targets and Therapies
Forschungsfeld(er) Helmholtz Diabetes Center
PSP-Element(e) G-502890-001
Scopus ID 85040185985
PubMed ID 29275360
Erfassungsdatum 2018-01-24